Inactive Instrument

Roche Holding AG Share Price Xetra

Equities

RHO5

CH0012032048

Pharmaceuticals

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 60B 66.19B 61.44B 5,531B Sales 2025 * 63.79B 70.38B 65.32B 5,881B Capitalization 182B 201B 186B 16,759B
Net income 2024 * 13.46B 14.85B 13.78B 1,241B Net income 2025 * 14.87B 16.4B 15.23B 1,371B EV / Sales 2024 * 3.27 x
Net Debt 2024 * 14.25B 15.72B 14.59B 1,314B Net Debt 2025 * 8.18B 9.03B 8.38B 754B EV / Sales 2025 * 2.98 x
P/E ratio 2024 *
13.1 x
P/E ratio 2025 *
12 x
Employees 1,03,605
Yield 2024 *
4.32%
Yield 2025 *
4.47%
Free-Float 88.91%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 49 01/03/01
Chairman 57 01/08/01
Director of Finance/CFO 57 01/11/01
Members of the board TitleAgeSince
Director/Board Member 72 03/15/03
Director/Board Member 59 -
Director/Board Member 66 01/96/01
More insiders
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW